2005
DOI: 10.1016/s0002-9440(10)61252-7
|View full text |Cite
|
Sign up to set email alerts
|

Matrix Contraction by Dermal Fibroblasts Requires Transforming Growth Factor-β/Activin-Linked Kinase 5, Heparan Sulfate-Containing Proteoglycans, and MEK/ERK

Abstract: Scarring is characterized by excessive synthesis and contraction of extracellular matrix. Here, we show that fibroblasts from scarred (lesional) areas of patients with the chronic fibrotic disorder diffuse scleroderma [diffuse systemic sclerosis (dSSc)] show an enhanced ability to adhere to and contract extracellular matrix, relative to fibroblasts from unscarred (nonlesional) areas of dSSc patients and dermal fibroblasts from normal, healthy individuals. The contractile abilities of normal and dSSc dermal fib… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

5
132
1

Year Published

2007
2007
2008
2008

Publication Types

Select...
8

Relationship

5
3

Authors

Journals

citations
Cited by 123 publications
(138 citation statements)
references
References 48 publications
5
132
1
Order By: Relevance
“…Fibrotic diseases are characterized by the failure to terminate normal tissue repair and the persistence of myofibroblasts within lesions (Gabbiani, 2003;Shi-wen et al, 2004;Chen et al, 2005). Myofibroblast formation can be driven by many processes, including tension, TGFβ, thrombin, ET1 and CCN2 (Arora et al, 1999;Hinz et al, 2001;Shephard et al, 2004;Shi-wen et al, 2004;Shi-wen et al, 2006a;Shi-wen et al, 2006b;Chen et al, 2005;Uehta et al, 1997;Leask and Abraham, 2004;Leask and Abraham, 2006;Goffin et al, 2006;Kennedy et al, 2007).…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Fibrotic diseases are characterized by the failure to terminate normal tissue repair and the persistence of myofibroblasts within lesions (Gabbiani, 2003;Shi-wen et al, 2004;Chen et al, 2005). Myofibroblast formation can be driven by many processes, including tension, TGFβ, thrombin, ET1 and CCN2 (Arora et al, 1999;Hinz et al, 2001;Shephard et al, 2004;Shi-wen et al, 2004;Shi-wen et al, 2006a;Shi-wen et al, 2006b;Chen et al, 2005;Uehta et al, 1997;Leask and Abraham, 2004;Leask and Abraham, 2006;Goffin et al, 2006;Kennedy et al, 2007).…”
Section: Discussionmentioning
confidence: 99%
“…Myofibroblast formation can be driven by many processes, including tension, TGFβ, thrombin, ET1 and CCN2 (Arora et al, 1999;Hinz et al, 2001;Shephard et al, 2004;Shi-wen et al, 2004;Shi-wen et al, 2006a;Shi-wen et al, 2006b;Chen et al, 2005;Uehta et al, 1997;Leask and Abraham, 2004;Leask and Abraham, 2006;Goffin et al, 2006;Kennedy et al, 2007). These processes cooperate in inducing myofibroblast persistence within the milieu of tissue repair and fibrosis (Arora et al, 1999;Hinz et al, 2001;Shephard et al, 2004;Shi-wen et al, 2006a;Shi-wen et al, 2006b).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Importantly, selective loss of N-, 2-O-, or 6-O-sulfates all lead to reduced TGF-␤1 activity (32). In lesion diffuse systemic sclerosis (dSSc) fibroblasts, syndecan-2 and syndecan-4 (members of the transmembrane HS proteoglycan, syndecan family) are markedly elevated compared with nonlesion dSSc or normal dermal fibroblasts, and HS side chains in these cells are required for TGF-␤-induced contractile phenotype (34). The role of specific sulfation (N-, 2-O-, and/or 6-Osulfation), however, was not addressed in this study.…”
mentioning
confidence: 99%
“…Syndecan-4 null fibroblasts are compromised in their ability to incorporate ␣-smooth muscle actin into stress fibers and this effect is more pronounced under conditions of serum starvation (40). This defect was corrected when rat syndecan-4 was expressed in these cells (Fig.…”
Section: Zsyndecan-4 Localizes To Focal Adhesions and Can Restore ␣-Smentioning
confidence: 97%